Triazine Derivative as Putative Candidate for the Reduction of Hormone-Positive Breast Tumor: In Silico, Pharmacological, and Toxicological Approach

Background and objectives: Breast cancer is a heterogeneous disease that poses the highest incidence of morbidity among women and presents many treatment challenges. In search of novel breast cancer therapies, several triazine derivatives have been developed for their potential chemotherapeutic acti...

Full description

Bibliographic Details
Main Authors: Muhammad Tayyab Imtiaz, Fareeha Anwar, Uzma Saleem, Bashir Ahmad, Sundas Hira, Yumna Mehmood, Manal Bashir, Saima Najam, Tariq Ismail
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Pharmacology
Subjects:
NMU
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.686614/full